thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q28087719-D19BBB43-8CAD-4626-8758-F9451C0BD932
Q28087719-D19BBB43-8CAD-4626-8758-F9451C0BD932
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28087719-D19BBB43-8CAD-4626-8758-F9451C0BD932
Improving natural killer cell cancer immunotherapy
P2860
Q28087719-D19BBB43-8CAD-4626-8758-F9451C0BD932
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28087719-D19BBB43-8CAD-4626-8758-F9451C0BD932
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5da03f612d3fc736cf1c4d1e9c391ad55de91f69
P2860
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.